Bio-Rad Laboratories (BIO) Long-Term Deferred Tax (2009 - 2019)

Bio-Rad Laboratories (BIO) has reported Long-Term Deferred Tax for 11 consecutive years, with $138.0 million the latest figure, recorded in Q4 2019.

• On a quarterly basis, Long-Term Deferred Tax rose 80.87% year-over-year to $138.0 million in Q4 2019; TTM through Dec 2019 was $138.0 million, a 80.87% increase from a year earlier, with the FY2019 full-year figure at $138.0 million, up 80.87% from the prior year.
• Long-Term Deferred Tax was $138.0 million for Q4 2019 at Bio-Rad Laboratories, up from $76.3 million in the prior quarter.
• Over five years, Long-Term Deferred Tax peaked at $138.0 million in Q4 2019 and troughed at $76.3 million in Q4 2018.
• A 5-year average of $102.2 million and a median of $99.5 million in 2015 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax sank 32.77% in 2017 and jumped 80.87% in 2019, its largest moves.
• Over 5 years, Long-Term Deferred Tax stood at $99.5 million in 2015, then climbed by 18.39% to $117.8 million in 2016, then slumped by 32.77% to $79.2 million in 2017, then retreated by 3.66% to $76.3 million in 2018, then surged by 80.87% to $138.0 million in 2019.
• The last three Long-Term Deferred Tax figures came in at $138.0 million (Q4 2019), $76.3 million (Q4 2018), and $79.2 million (Q4 2017), per Business Quant data.